About 200 reports

Global Alzheimer’s Disease Therapeutics and Diagnostics Market 2018-2028 ##.

  • Dementia
  • Diagnostics
  • Mental Health
  • World
  • Market Size

GLOBAL ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST 2018-2026 ##.

  • Dementia
  • Therapy
  • World

EUROPE ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST 2018-2026 ##.

  • Dementia
  • Mental Health
  • Therapy
  • Europe
  • Market Size

NORTH AMERICA ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST 2018-2026 ##.

  • Dementia
  • Mental Health
  • Therapy
  • North America
  • Market Size

ASIA PACIFIC ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST 2018-2026 ##.

  • Dementia
  • Therapy
  • APAC
  • Market Size
  • Global Alzheimer's Disease Market, By Diagnostics and Biomarkers
  • Global Alzheimer's Disease Market , By Diagnostics and Biomarkers ,By Value (USD

One in six people over ## have dementia.

  • Dementia
  • Axovant Sciences Ltd.
  • Biotie Therapies Corp.
  • Novartis AG
  • Pfizer Inc.

At present days, neurodegenerative diseases represent one of the main causes of death in the industrialized economy.

  • Dementia
  • Mental Health
  • Psychotic Disorder
  • Therapy
  • World
  • RELATED REPORTS
  • UNMET NEEDS AND CHALLENGES IN AD BIOMARKERS

Healthcare TABLE OF CONTENTS (##/ ##) ##.

  • Dementia
  • United States
  • World
  • Boehringer Ingelheim GmbH
  • Pfizer Inc.

TABLE ##.

  • Dementia
  • World
  • Forecast
  • Market Size
  • Ascom Holding AG

Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast 2016-2026: Opportunities for Leading Companies ##.

  • Dementia
  • Diagnostics
  • Mental Health
  • World
  • Market Size

Cognition and Memory Enhancement Drugs: Technologies and Global Markets Chapter ## Introduction Study Goals and Objectives Reasons for Doing This Study Scope of Report Information Sources and Methodology Intended Audience Geographic Breakdown Analyst’s Credentials Related BCC Research Report

  • Dementia
  • Mental Health
  • World
  • DIAGNOSTIC ASSAY - ALZHEIMER'S DISEASE (CSF) - PRODUCT STATUS
  • Device Class

After the tax credit of £##. ## ## m (## ## :£##. ##m), the loss after taxation for the period was £##. ##m(2014: £##. ##m).

  • Biomarker
  • Dementia
  • Genomics Proteomics And Enabling Technology
  • United Kingdom
  • Proteome Sciences
  • PRESENTS THE COMMONLY USED DIAGNOSTIC GUIDELINES FOR AD.
  • COMMONLY USED DIAGNOSTIC GUIDELINES FOR ALZHEIMER'S DISEASE

ALZHEIMER' S & DEMENTIA; ##(##): ##-##.

  • Dementia
  • Allergan plc
  • Biogen Idec Inc.
  • Eisai Co., Ltd.
  • Novartis AG
  • 3.1 DISEASE BACKGROUND
  • 2 Amyotrophic Lateral Sclerosis: Executive Summary

Frontotemporal Degeneration, ##(##-##), pp. ##-##. doi: ##. ##/ ##. 2014. ##.

  • Dementia
  • Japan
  • United States
  • World
  • Forecast
  • Year 2015
  • GLOBAL ALZHEIMER'S DISEASE DRUGS MARKET - MERGERS AND ACQUISITIONS, 2008 - 2016

This is one of first times the new diagnostic criteria by the International Working Group were applied in a large clinical trial.

  • Dementia
  • World
  • Biogen Idec Inc.
  • Eisai Co., Ltd.
  • Roche Group
  • Unmet Needs and Opportunities in ALS
  • 7 Unmet Needs and Opportunity Assessment

The reason for this is, one, it' s a rare disease; two, there' s no diagnostic test that can confirm or exclude the diagnosis of ALS. "

  • Dementia
  • Therapy
  • United States
  • Forecast
  • Ionis Pharmaceuticals, Inc.
  • 2.4 Epidemiology Patterns: Prevalence, Patient Segmentation, and Diagnostic and Treatment Usage Rates
  • NEURODEGENERATIVE DISORDERS, SEVEN MAJOR MARKETS, EPIDEMIOLOGY PATTERNS FOR

However, Amyvid was only approved as an adjunct to other clinical diagnostic evaluations, and the scan by itself cannot be used to make a diagnostic assessment in AD.

  • Dementia
  • Biogen Idec Inc.
  • Novartis AG
  • Roche Group
  • Sanofi S.A.
  • DAMD TREATMENT MARKET IN EMEA
  • OTHER PROMINENT VENDORS

You can easily book an appointment with one online.

  • Dementia
  • Allergan plc
  • Eisai Co., Ltd.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Executive Summary
  • 3.1 DISEASE BACKGROUND

PLoS ONE; ##(##): e##.

  • Dementia
  • Spain
  • United States
  • World
  • Forecast
  • MARKET DRIVERS

AD is one of the most common types of NDDs.

  • Dementia
  • Eli Lilly & Co.
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • BY DIAGNOSTICS
  • Alzheimer's Disease Diagnostics and Therapeutics Market: Revenue Share (% ), by Type, Global, 2018

There is one rural insurance scheme, which has much lower reimbursement levels and service coverage than the urban ones.

  • Dementia
  • Mental Health
  • World
  • Market Size
  • F. Hoffmann-La Roche Ltd.
  • IDENTIFYING FACTORS THAT IMPEDE MARKET GROWTH

You can easily book an appointment with one online.

  • Dementia
  • Forecast
  • Allergan plc
  • Eisai Co., Ltd.
  • Novartis AG
  • LIST OF TABLES AND FIGURES

MCKEITH DIAGNOSTIC CRITERIA FOR DLB Source: McKeith, 1996.

  • Dementia
  • United States
  • Forecast
  • Promising Drugs in Development for AD

Elenbecestat' s success will largely depend on the development of robust diagnostic biomarkers.

  • Dementia
  • Allergan plc
  • Eisai Co., Ltd.
  • Novartis AG
  • Roche Group
  • CAUSE OF THE DISEASE
  • ABBREVIATIONS AND ACRONYMS USED IN THE REPORT

Age and diagnostic performance of Alzheimer disease CSF biomarkers.

  • Dementia
  • Mental Health
  • Pathology
  • India
  • Sep 07, 2017: Oligomerix Awarded National Institute on Aging SBIR Grant for Development of Alzheimer's Disease Specific Biomarker
  • Apr 17, 2018: Cogstate Scientists Contribute to New Research Framework to Redefine Alzheimer's Disease

It may also enable a low-cost, pre-clinical AD diagnostic assay.

  • Dementia
  • Healthcare
  • Pharmaceutical
  • Salicylic Acid
  • United States
  • COMPANION DIAGNOSTIC TEST - CORTICOBASAL DEGENERATION - PRODUCT STATUS
  • COMPANION DIAGNOSTIC TEST - OSTEOPOROSIS - PRODUCT DESCRIPTION

IT AFFECTS ## IN ##, ## TO ## IN ##, ## BIRTHS.

  • Clinical Trial
  • Dementia
  • Hospital
  • Mental Health
  • AutoGenomics, Inc.

GlobalData Therapy Area Oncology Cardiovascular Gastrointestinal Immunology Infectious Disease Metabolic Disorders No. of Deals ## ## ## ## ## ## Deal Value (US$ million) ##. ## NA NA NA NA NA Karolinska Institute, Medical Devices Deals, 2012 to YTD 2018 KAROLINSKA INSTI

  • Cancer
  • Dementia
  • Sweden
  • Karolinska Institutet Holding
  • Takeda Pharmaceutical Company Limited
  • METHODOLOGY FOR QUANTIFICATION OF PATIENT NUMBERS
  • REFERENCES

HOWEVER MOST OF THESE STUDIES DIFFER IN THE DIAGNOSTIC CRITERIA USED TO DETERMINE PREVALENT CASES.

  • Dementia
  • Mental Health
  • Pathology

Alzheimer's disease

4385 5000 3900
  • DSM-IV-TR DIAGNOSTIC CRITERIA FOR 294.1X DEMENTIA OF THE ALZHEIMER'S TYPE
  • DSM-IV-TR DIAGNOSTIC CRITERIA FOR 294.1X DEMENTIA OF THE ALZHEIMER'S TYPE

Expert Opinion on Medical Diagnostics, ##(##), ##-## < DOI> ##. ##/ ##. ##. ##. ##< / DOI>.

  • Dementia
  • East Asia
  • European Union
  • Japan
  • United States